AI Science Tracker
EN

Personalized prediction of immunotherapy response in lung cancer patients using advanced radiomics and deep learning

National Yang Ming Chiao Tung University; University of Texas Southwestern Medical Center · 30 Sep 2024 · medicine

Discovery

Personalized prediction of immunotherapy response in lung cancer patients using advanced radiomics and deep learning

Source check: Source checked. Not independent scientific confirmation.

Finding: Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Radiomics machine-learning model

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods specify the AI/learned analysis that enabled the case-specific result: Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation.
Test and result
Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11440728/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.